Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (including mixed tocopherols and tocotrienols) has been extensively studied for its potential role in cardiovascular disease (CVD) prevention and treatment, primarily due to its antioxidant properties. Early observational studies in the 1990s suggested that higher vitamin E intake was associated with lower rates of heart disease, leading to scientific interest and widespread supplementation. Vitamin E can reduce oxidative stress and prevent LDL cholesterol oxidation, processes implicated in atherosclerosis, which is a key factor in CVD.

However, results from randomized controlled trials (RCTs) and meta-analyses have generally been disappointing. Large-scale studies such as the HOPE, GISSI-Prevenzione, and Women's Health Study found no significant benefit of vitamin E supplementation (at typical doses) in reducing cardiovascular events or mortality. Some studies have even raised concerns about potential harm or increased risk of heart failure with high-dose supplementation. Tocotrienols, a lesser-studied form of vitamin E, have shown some promise in preclinical and small human studies, but robust clinical data are lacking.

As a result, current guidelines from major health organizations do not recommend vitamin E supplementation for cardiovascular disease prevention or treatment in the general population. The overall evidence is mixed to weak, with most high-quality trials showing little or no benefit. Therefore, while the use of vitamin E for CVD is "scientific" in origin, the supporting evidence is rated low (2/5), and supplementation is not broadly recommended for this purpose.

More about Vitamin E (Mixed Tocopherols and Tocotrienols)
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Vitamin E (Mixed Tocopherols and Tocotrienols)

Products containing Vitamin E (Mixed Tocopherols and Tocotrienols)